Beta Bionics

Beta Bionics

Beta Bionics

At Beta Bionics, Inc., we are developing a bionic pancreas system called the iLet. Our first commitment is to the type 1 diabetes (T1D) community.
Raised
$63M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$63,000,000
Venture capital (Series B) - 2019
ArrowMark Partners LifeSci Venture Partners Dexcom
Team Size
1–10
Employees
$63,000,000 Venture capital (Series B)
Xconomy

Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests